BARDA Plans Four-Pronged Approach To Future Pandemics
A new paper from the US Biomedical Advanced Research and Development Authority (BARDA) suggests a future pandemic strategy that leans heavily on flexibility, collaborations with industry, and swift regulatory authorization.
You may also be interested in...
As a part of the end-of year omnibus bill, BARDA and FDA received funding to boost US’s domestic manufacturing of biomedical devices to prepare for future pandemics.
The Biomedical Advanced Research and Development Authority says lessons learned from the pandemic has better prepared the agency to respond to future health emergencies, including a new infectious disease division.
This feature compiles news briefs on a range of US regulatory and legal happenings. This week: Medtronic seeks HeartWare batteries; companies sign health equity pledge; insulin dosing app cleared; recall on field decontamination kits; and the renewal of an FDA panel.